663. Can Oncolytic Measles Virus Targeted to CD20 Recapitulate Any of the Effects of Rituximab in the Treatment of Acute Lymphoblastic Leukemia?

Journal article

Open access

Peer reviewed

Katharine Bailey, Aditi Dey, Sarah Aref, Lucile Broyer and Adele K. Fielding

Molecular therapy, Vol.24, pp.S262-S263

05/2016

Files and links (1)

url

https://doi.org/10.1016/S1525-0016(16)33471-2View

Published (Version of record) Open

1 Record Views

Title: 663. Can Oncolytic Measles Virus Targeted to CD20 Recapitulate Any of the Effects of Rituximab in the Treatment of Acute Lymphoblastic Leukemia?
Creators - without role: Katharine Bailey - Cancer Institute, UCL, London, United Kingdom
Aditi Dey - Cancer Institute, UCL, London, United Kingdom
Sarah Aref - Cancer Institute, UCL, London, United Kingdom
Lucile Broyer - Light Chain Bioscience
Adele K. Fielding - Cancer Institute, UCL, London, United Kingdom
Publication Details: Molecular therapy, Vol.24, pp.S262-S263
Publisher: Elsevier Inc
Identifiers: 9921550708331
Academic Unit: King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article